Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 13, 2026

Jan. 13, 2026

Aqua free startet mit „Shower2go“ in den B2C-Markt: Mobile Reisedusche für sicheres Duschen ohne Legionellen für unterwegs

GlobeNewswire

Jan. 13, 2026

Aqua free enters the B2C market with “Shower2go”: a portable travel shower for safer showering on the go – helping to reduce exposure to Legionella

GlobeNewswire

Jan. 13, 2026

Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions

GlobeNewswire

Jan. 13, 2026

Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy

GlobeNewswire

Jan. 13, 2026

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue and 2026 Revenue Guidance and Anticipated Development Milestones

GlobeNewswire

Jan. 13, 2026

Voting Rights and Shares Capital of the Company

GlobeNewswire

Jan. 13, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

GlobeNewswire

Jan. 13, 2026

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

GlobeNewswire

Jan. 13, 2026

Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

GlobeNewswire

Jan. 13, 2026

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

GlobeNewswire

Jan. 13, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Jan. 13, 2026

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

GlobeNewswire

Jan. 13, 2026

Kaneka Medical America LLC Announces U.S. Launch of WaveSelect 1014 Guidewire

GlobeNewswire

Jan. 13, 2026

Southern Pain and Spine Specialists Announces Dr. Ammar Alamarie, MD Named Castle Connolly Top Doctor for Pain Management in 2025 for Second Consecutive Year

GlobeNewswire

Jan. 13, 2026

OC WASTE & RECYCLING PARTNERS WITH AGROMIN TO EXPAND COMPOST AND MULCH PROGRAM

GlobeNewswire

Jan. 13, 2026

The Ebony Canal Scores NAACP Image Award Nomination for Outstanding Short Form Documentary

GlobeNewswire

Jan. 13, 2026

Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026

GlobeNewswire

Jan. 13, 2026

La FDA américaine accorde la désignation « Breakthrough Therapy » à l’IPN60340 (ICT01) d’Ipsen dans la leucémie myéloïde aiguë de première ligne chez les patients inéligibles à une chimiothérapie intensive

GlobeNewswire

Jan. 13, 2026

U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia

GlobeNewswire

Jan. 13, 2026

Blue Cross and Blue Shield of Minnesota Adds Virtual Primary Care from Doctor On Demand to Provider Network

GlobeNewswire